Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the effects of an investigational blood thinner, apixaban, in
preventing venous thromboembolic (VTE) recurrence or death in patients who have completed
their intended treatment for deep vein thrombosis (DVT) or pulmonary embolism (PE)